Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

191 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neuropeptide signaling through neurokinin-1 and neurokinin-2 receptors augments antigen presentation by human dendritic cells.
Ohtake J, Kaneumi S, Tanino M, Kishikawa T, Terada S, Sumida K, Masuko K, Ohno Y, Kita T, Iwabuchi S, Shinohara T, Tanino Y, Takemura T, Tanaka S, Kobayashi H, Kitamura H. Ohtake J, et al. Among authors: masuko k. J Allergy Clin Immunol. 2015 Dec;136(6):1690-1694. doi: 10.1016/j.jaci.2015.06.050. Epub 2015 Sep 12. J Allergy Clin Immunol. 2015. PMID: 26371842 Free article. No abstract available.
Extracts of Larix Leptolepis effectively augments the generation of tumor antigen-specific cytotoxic T lymphocytes via activation of dendritic cells in TLR-2 and TLR-4-dependent manner.
Koizumi S, Masuko K, Wakita D, Tanaka S, Mitamura R, Kato Y, Tabata H, Nakahara M, Kitamura H, Nishimura T. Koizumi S, et al. Among authors: masuko k. Cell Immunol. 2012 Mar-Apr;276(1-2):153-61. doi: 10.1016/j.cellimm.2012.05.002. Epub 2012 May 17. Cell Immunol. 2012. PMID: 22677561 Free article.
Toll-like receptor-dependent IL-12 production by dendritic cells is required for activation of natural killer cell-mediated Type-1 immunity induced by Chrysanthemum coronarium L.
Tanaka S, Koizumi S, Masuko K, Makiuchi N, Aoyagi Y, Quivy E, Mitamura R, Kano T, Ohkuri T, Wakita D, Chamoto K, Kitamura H, Nishimura T. Tanaka S, et al. Among authors: masuko k. Int Immunopharmacol. 2011 Feb;11(2):226-32. doi: 10.1016/j.intimp.2010.11.026. Epub 2010 Dec 7. Int Immunopharmacol. 2011. PMID: 21144920
Efficacy and safety of ivermectin in patients with mild COVID-19 in Japan and Thailand.
Mikamo H, Takahashi S, Yamagishi Y, Hirakawa A, Harada T, Nagashima H, Noguchi C, Masuko K, Maekawa H, Kashii T, Ohbayashi H, Hosokawa S, Maejima K, Yamato M, Manosuthi W, Paiboonpol S, Suganami H, Tanigawa R, Kawamura H; IVERMILCO Study Group. Mikamo H, et al. Among authors: masuko k. J Infect Chemother. 2024 Jun;30(6):536-543. doi: 10.1016/j.jiac.2023.12.012. Epub 2023 Dec 27. J Infect Chemother. 2024. PMID: 38154616 Free article. Clinical Trial.
191 results